Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 2,470 shares at $5.87 ($13K) on 2019-07-25, disclosed to the SEC on 2019-09-20.
Open-market purchase of $13k CPIX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.87 | 65 | $382 | 2.8% |
| 2 | $5.86 | 65 | $381 | 2.8% |
| 3 | $5.87 | 65 | $382 | 2.8% |
| 4 | $5.83 | 65 | $379 | 2.8% |
| 5 | $5.94 | 65 | $386 | 2.9% |
| 6 | $6.15 | 130 |
| $800 |
| 5.9% |
| 7 | $6.17 | 65 | $401 | 3.0% |
| 8 | $6.07 | 65 | $395 | 2.9% |
| 9 | $6.02 | 130 | $783 | 5.8% |
| 10 | $5.91 | 65 | $384 | 2.8% |
| 11 | $5.78 | 65 | $376 | 2.8% |
| 12 | $5.49 | 65 | $357 | 2.6% |
| 13 | $5.62 | 130 | $731 | 5.4% |
| 14 | $5.51 | 65 | $358 | 2.7% |
| 15 | $5.43 | 65 | $353 | 2.6% |
| 16 | $5.49 | 65 | $357 | 2.6% |
| 17 | $5.31 | 65 | $345 | 2.6% |
| 18 | $5.38 | 65 | $350 | 2.6% |
| 19 | $5.19 | 130 | $675 | 5.0% |
| 20 | $5.04 | 130 | $655 | 4.9% |
| 21 | $5.14 | 65 | $334 | 2.5% |
| 22 | $4.79 | 65 | $311 | 2.3% |
| 23 | $4.91 | 130 | $638 | 4.7% |
| 24 | $5.19 | 65 | $337 | 2.5% |
| 25 | $5.38 | 65 | $350 | 2.6% |
| 26 | $5.02 | 65 | $326 | 2.4% |
| 27 | $5.18 | 130 | $673 | 5.0% |
| 28 | $4.97 | 65 | $323 | 2.4% |
| 29 | $4.93 | 130 | $641 | 4.7% |
| 30 | $5.21 | 65 | $339 | 2.5% |
| Total | $5.47 avg | 2,470 | $13K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |